AIG Hospitals Study Finds Intestinal Ultrasound Cuts Costs and Carbon Emissions in IBD Monitoring

AIG Hospitals Study Finds Intestinal Ultrasound Cuts Costs and Carbon Emissions in IBD Monitoring

Reducing the environmental impact of healthcare while maintaining quality and affordability is becoming an important priority. A study by Hyderabad-based AIG Hospitals highlights how intestinal ultrasound could support this goal in the long-term management of inflammatory bowel disease (IBD).

The research, led by Dr Hardik Rughwani, was published in Alimentary Pharmacology & Therapeutics. The EVERGREEN-IBD study found that intestinal ultrasound had the lowest operational carbon emissions and hospital cost among the diagnostic procedures evaluated, supporting its use for routine monitoring when clinically suitable.

IBD includes Crohn’s disease and ulcerative colitis, conditions that often require regular investigations over many years. Repeated diagnostic procedures consume energy, water and medical supplies, while also generating waste. Healthcare accounts for an estimated 4.4–5% of global greenhouse gas emissions, making resource-efficient diagnostic choices increasingly relevant.

Conducted at AIG Hospitals in December 2025, the study assessed the carbon footprint of laboratory investigations, colonoscopy and enteroscopy, CT, MRI and intestinal ultrasound using a common methodology.

The estimated emissions per examination were:

  • Intestinal ultrasound: 0.85 kg CO₂ equivalent
  • Colonoscopy/enteroscopy: 3.87 kg CO₂ equivalent
  • CT scan: 5.82 kg CO₂ equivalent
  • MRI: 21.25 kg CO₂ equivalent

The findings showed that intestinal ultrasound produced approximately 96% less carbon emissions than MRI per examination.

The financial analysis also favoured ultrasound. Its hospital cost at AIG was around 50% lower than colonoscopy and approximately one-sixth the cost of MR enterography, an MRI-based bowel examination.

Dr D Nageshwar Reddy, Chairman, AIG Hospitals, said “The future of healthcare must bring together clinical excellence, affordability and environmental responsibility. For chronic diseases, patients need care over many years, the choices we make repeatedly can have a substantial cumulative impact. When a less resource-intensive investigation can reliably answer the clinical question, its use deserves serious consideration. Sustainability should be built into how we deliver care along with patient safety and clinical need.”

Intestinal ultrasound is performed by moving an ultrasound probe across the abdomen to examine the bowel and identify signs of inflammation. The technique does not use ionising radiation and generally does not require sedation or bowel preparation. It can be carried out during a clinic visit and help doctors evaluate disease activity and response to treatment. Its application in IBD monitoring is already recognised in clinical guidance.

Dr Hardik Rughwani, lead author and Consultant – Gastroenterologist at AIG Hospitals, said “IBD management continues for years, sometimes decades, making it important to examine both the cost and the resources used by each investigation. We combined hospital activity data with measurements and estimates of electricity, water, consumables and waste to compare these tests consistently. Intestinal ultrasound stood out for its low operational carbon footprint and lower hospital cost. The practical need is to expand access to appropriately performed ultrasound and integrate it into suitable follow-up assessments. We now need studies following individual patients to establish the savings achievable across their complete course of care.”

The study points to intestinal ultrasound as a promising option for more affordable and environmentally conscious IBD follow-up. Wider adoption, supported by trained professionals and further patient-level research, could help reduce the cumulative cost and environmental burden of long-term care.

(Photo credit: www.aighospitals.com)

Leave a Reply

Your email address will not be published. Required fields are marked *